Multi-component Workplace Energy Balance Intervention (WorkACTIVE-P)

Pennington Biomedical Research Center

Status: Completed

Conditions: Abdominal Obesity

Treatments: Behavioral: Intervention Group

Study type: Interventional

Funder types: Other

Identifiers

NCT02561611

PBRC 2015-024

R21OH010785-01A1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of the WorkACTIVE-P study is to assess the outcome of an innovative multi-component intervention focused on increasing energy expenditure and re-balancing the disrupted energy balance equation of sedentary workplaces with an ultimate target of reducing workers' abdominal obesity.

Full description

The energy expenditure intervention includes replacing workplace sedentary time with access to a dedicated pedal desk and increasing steps/day with wearable monitors. Both components are incorporated into an electronically-delivered behavior monitoring and support infrastructure, thus enabling continuous management. The investigators will utilize pedaldesks manufactured and owned by Pennington Biomedical Research Center to conduct this study at Blue Cross Blue Shield of Louisiana offices in Baton Rouge, La. 40 individuals will be recruited and randomized to either a control arm or combined Walk More Pedal Desk (WMPD) intervention. Primary (MRI-determined visceral adipose tissue) and secondary (changes in body weight, total adipose tissue, subcutaneous adipose tissue, blood pressure, blood lipids, fasting glucose and insulin, HbA1-c, free-living accelerometer-determined walking, time spent in sedentary behavior, exercise, and dietary intake) outcomes will be assessed at baseline and month 3.

Enrollment: 40 patients

Sex: All

Ages: 18 to 64 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• BMI: > or equal to 25.0 kg/m2 and < or equal to 40 kg/m2
• Waist Circumference: >102 cm (men) or > 88 cm (women)
• Any one of the other four defining risk factors defining metabolic syndrome (Triglycerides > or equal to 150 mg/dL , HDL Cholesterol < 40 mg/dL (men) or < 50 mg/dL (women), Resting blood pressure > or equal to 130 mm Hg systolic / 85 mm Hg diastolic, Fasting glucose > or equal to 110 mg/dL)

Exclusion criteria

• Systolic blood pressure > 179 mmHg and/or diastolic blood pressure > 99 mmHg
• Self-reported Type 1 or Type 2 diabetes, or use of diabetes-related medications
• Significant CVD or disorders
• Other significant medical conditions including but not limited to implants that may interfere with MRI, chronic respiratory, gastrointestinal, neuromuscular, or psychiatric conditions, malignancies in the past 5 years, with the exception of skin cancer therapeutically controlled, endocrine (including diabetes), any other medical conditions or disease (including arthritis) that is life threatening or that can interfere with or be aggravated by exercise.
• Poor compliance to activity monitors

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

40 participants in 2 patient groups

Control Group

No Intervention group

Description:

* Usual Working Condition Group (UWC) * The no-intervention control condition will be asked to maintain their usual work and lifestyle throughout the study. Participants may be contacted by Pennington Biomedical staff during the intervention.

Intervention Group

Experimental group

Description:

* Combined Intervention (Walk More and Pedal Desk; WMPD) * Participants in the WMPD condition will engage in both step-counting (Walk More, WM) and pedal desk (PD) intervention components.

Treatment:

Behavioral: Intervention Group